The Zika Virus (PRVABC59) PCR External Quality Control is a molecular reference material designed to evaluate the analytical performance of RT-PCR assays targeting Zika virus RNA. This external quality control (EQC) material is used to monitor assay sensitivity, specificity, amplification efficiency, and overall workflow integrity in molecular diagnostic laboratories and research environments.
Background on Zika Virus and PRVABC59 Strain
Zika virus (ZIKV) is an enveloped, positive-sense single-stranded RNA virus belonging to the genus Flavivirus within the family Flaviviridae. Detailed genomic and virological information is available through:
-
CDC Zika virus overview:
https://www.cdc.gov/zika/index.html -
NIH National Institute of Allergy and Infectious Diseases (NIAID):
https://www.niaid.nih.gov/diseases-conditions/zika-virus -
NCBI Virus database:
https://www.ncbi.nlm.nih.gov/labs/virus/vssi/#/virus?SeqType_s=Nucleotide&VirusLineage_ss=Zika%20virus
The PRVABC59 strain is a well-characterized Zika virus isolate obtained during the 2015 outbreak in the Americas. Genomic sequence information is accessible via:
-
NCBI GenBank:
https://www.ncbi.nlm.nih.gov/genbank/ -
NIH PubMed references for PRVABC59 molecular characterization:
https://pubmed.ncbi.nlm.nih.gov/
Purpose of PCR External Quality Control
External Quality Control (EQC) materials are independent control samples used to:
-
Verify assay accuracy
-
Monitor analytical sensitivity
-
Confirm amplification efficiency
-
Detect reagent degradation
-
Identify contamination or inhibition
General molecular diagnostic quality assurance principles are described by:
-
CDC Laboratory Quality Management System:
https://www.cdc.gov/labquality/index.html -
U.S. FDA Molecular Diagnostic Guidance:
https://www.fda.gov/medical-devices/in-vitro-diagnostics -
NIH assay validation guidance:
https://www.ncbi.nlm.nih.gov/books/NBK305/
Assay Context: RT-PCR Detection of Zika Virus
Reverse transcription polymerase chain reaction (RT-PCR) is the primary molecular method for detecting Zika virus RNA. CDC molecular testing guidance:
https://www.cdc.gov/zika/laboratories/types-of-tests.html
RT-PCR workflow components:
-
RNA extraction
-
Reverse transcription to cDNA
-
Amplification using specific primers/probes
-
Real-time fluorescence detection
-
Cycle threshold (Ct) analysis
PCR fundamentals are documented by:
-
NIH PCR technical resource:
https://www.genome.gov/genetics-glossary/Polymerase-Chain-Reaction -
NCBI Bookshelf molecular biology reference:
https://www.ncbi.nlm.nih.gov/books/NBK21114/
Characteristics of Zika Virus (PRVABC59) PCR External Quality Control
Typical EQC format may include:
-
Inactivated whole virus or synthetic RNA fragment
-
Quantified RNA concentration
-
Defined genome copy number per mL
-
Stability data under controlled storage conditions
-
Compatibility with CDC-recommended primer/probe sets
Quality control best practices are described by:
-
CDC Biosafety in Microbiological and Biomedical Laboratories (BMBL):
https://www.cdc.gov/labs/BMBL.html -
NIH Office of Research Services biosafety guidelines:
https://ors.od.nih.gov/sr/dohs/safety/laboratory/Pages/default.aspx
Analytical Performance Monitoring
When used appropriately, the Zika Virus (PRVABC59) PCR External Quality Control supports evaluation of:
-
Limit of detection (LOD)
-
Reproducibility (intra- and inter-run variability)
-
Ct value consistency
-
Amplification efficiency (%)
-
Linear dynamic range
FDA analytical validation framework:
https://www.fda.gov/regulatory-information/search-fda-guidance-documents/analytical-procedures-and-methods-validation
NIH reproducibility and rigor guidance:
https://www.nih.gov/research-training/rigor-reproducibility
Application Areas
The Zika Virus (PRVABC59) PCR External Quality Control is applicable to:
-
Academic research laboratories
-
Public health surveillance programs
-
Molecular assay development
-
Proficiency testing exercises
-
Inter-laboratory comparison studies
CDC global health and arbovirus surveillance overview:
https://www.cdc.gov/globalhealth/healthprotection/fieldupdates/winter-2019/zika-response.html
NIH emerging infectious disease research:
https://www.niaid.nih.gov/diseases-conditions/emerging-infectious-diseases
Data Interpretation
Quality control material should produce expected Ct values within defined acceptance criteria. Deviations may indicate:
-
Instrument calibration issues
-
Reagent instability
-
Pipetting variability
-
RNA degradation
-
Inhibitory substances
Statistical quality control approaches in molecular diagnostics are discussed by:
-
National Institute of Standards and Technology (NIST):
https://www.nist.gov -
NIH biostatistics references:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4263697/
Technical Summary
-
Product Type: PCR External Quality Control (EQC)
-
Target: Zika Virus RNA (PRVABC59 strain)
-
Application: RT-PCR assay validation and performance monitoring
-
Format: RNA control material (inactivated or synthetic)
-
Use: Research and laboratory quality assurance
The Zika Virus (PRVABC59) PCR External Quality Control provides a standardized reference material for monitoring RT-PCR assay performance targeting Zika virus RNA. It supports molecular workflow verification, assay validation, and laboratory quality management in accordance with established molecular diagnostic standards.


![AffiCHECK® Zika Virus (PRVABC59) PCR External Quality Control [Mid Level]](https://affigen.com/cdn/shop/products/AffiCHECK_8138d4b5-73bb-4e51-b4f1-55a4d1d6051f_535x.png?v=1686503486)
